drug
anakinra
Marketedupdated 6mo agoby Sobi Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
Rheumatoid Arthritis
all catalysts(0)
nothing on the calendar yet
Trials studying anakinra
- —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- phase2Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- phase2A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
- phase2Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
- phase4A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF
- phase3A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
- phase2Open-label Study of Anakinra in MPS III
- —Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
News(2)
- BMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trialThe disclosure—which came ahead of a presentation of data from the Phase 1 Breakfree-2 study at the ACTRIMS-ECTRIMS meeting—follows Bristol Myers Squibb’s late summer revelation that it had paused…biospace · 27d ago
- BMS sheds light on patient death in CAR-T trial, wants to get program back on trackBristol Myers Squibb has shared more details with Fierce about the death of a patient who received the pharma's investigational CAR-T in a multiple sclerosis trial.fiercebiotech · 27d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that